ÂÜÀòÂÒÂ×

Gillian Cannon is an accomplished professional with extensive experience in the biopharmaceutical and healthcare sectors. Currently serving as Principal at Castle Tech Consulting since April 2019, Gillian also holds positions on multiple boards, including Xenon Pharmaceuticals Inc. and Our Future Health Trading Limited, among others. In addition to board roles, Gillian contributes to advisory capacities, such as with Veritas Data Research and Newcastle University. Prior experience includes leadership at Roivant Sciences, where Gillian was Head of Commercial Innovation and President of Alyvant, focusing on technology-driven pharmaceutical commercialization. Academically, Gillian holds a Bachelor of Science in Biochemistry from The University of Edinburgh and a PhD in Health Services Administration from Temple University.